Literature DB >> 6272223

Requirement for the C-terminal region of middle T-antigen in cellular transformation by polyoma virus.

U Novak, B E Griffin.   

Abstract

Deletions of polyoma virus DNA around the region that codes for the C-terminus of the viral middle T-antigen were created using a transforming fragment (BamH I/EcoR I) of viral DNA cloned in the plasmid vector pAT153. These species were recloned and assayed for their ability to transform Rat-1 cells in culture. Our results showed that whereas the DNA sequence between the presumed translational termination codon for the viral middle T-antigen and the single viral EcoR I site could be removed with no apparent effect on transformation, the removal of the termination codon itself or any amino acid coding sequences of this protein caused a drastic decrease in the transforming ability of the DNA. Transfection of Rat-1 cells with plasmids that contained viral DNA with deletions which corresponded to the last fourteen or more amino acids of the middle T-antigen never gave rise to cellular transformation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272223      PMCID: PMC326826          DOI: 10.1093/nar/9.9.2055

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  CELL-TRANSFORMING ABILITY OF A TEMPERATURE-SENSITIVE MUTANT OF POLYOMA VIRUS.

Authors:  M FRIED
Journal:  Proc Natl Acad Sci U S A       Date:  1965-03       Impact factor: 11.205

2.  Virus-specific early RNA in 3T6 cells infected by a tsA mutant of polyoma virus.

Authors:  B Cogen
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

3.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  pBR322 restriction map derived from the DNA sequence: accurate DNA size markers up to 4361 nucleotide pairs long.

Authors:  J G Sutcliffe
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

5.  Polyoma DNA: a physical map.

Authors:  B E Griffin; M Fried; A Cowie
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

6.  Host range mutants of polyoma virus.

Authors:  T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

7.  Extracellular nucleases of Pseudomonas BAL 31. I. Characterization of single strand-specific deoxyriboendonuclease and double-strand deoxyriboexonuclease activities.

Authors:  H B Gray; D A Ostrander; J L Hodnett; R J Legerski; D L Robberson
Journal:  Nucleic Acids Res       Date:  1975-09       Impact factor: 16.971

8.  5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells.

Authors:  A E Freeman; R V Gilden; M L Vernon; R G Wolford; P E Hugunin; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  Localization of gene functions in polyoma virus DNA.

Authors:  J Feunteun; L Sompayrac; M Fluck; T Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  15 in total

1.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses.

Authors:  J Forstová; N Krauzewicz; B E Griffin
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

Review 3.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen.

Authors:  W Markland; S H Cheng; B A Oostra; A E Smith
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

5.  DNA sequences required for specific and efficient initiation of transcription at the polyoma virus early promoter.

Authors:  P Jat; U Novak; A Cowie; C Tyndall; R Kamen
Journal:  Mol Cell Biol       Date:  1982-07       Impact factor: 4.272

6.  Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation.

Authors:  G G Carmichael; B S Schaffhausen; D I Dorsky; D B Oliver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Characterization of viable mutants of polyomavirus cold sensitive for maintenance of cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Construction and expression of a recombinant DNA gene encoding a polyomavirus middle-size tumor antigen with the carboxyl terminus of the vesicular stomatitis virus glycoprotein G.

Authors:  D Templeton; A Voronova; W Eckhart
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

9.  Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.

Authors:  G Carmichael; B S Schaffhausen; G Mandel; T J Liang; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  A frameshift mutation affecting the carboxyl terminus of the simian virus 40 large tumor antigen results in a replication- and transformation-defective virus.

Authors:  E D Lewis; S Chen; A Kumar; G Blanck; R E Pollack; J L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.